New Jersey legislation · 2026-2027 Regular Session
New Jersey A3675: HIV prophylaxis-authorizes pharmacists to dispense w/out individual prescription
Status: Failed, January 30, 2026
Authorizes pharmacists to dispense HIV prophylaxis without individual prescription under certain circumstances; mandates prescription benefits coverage.
What the bill says
An Act concerning pharmacists and supplementing Titles 17, 26, 45, and 52 of the Revised Statutes and Title 17B of the New Jersey Statutes.
From the introduced text, January 13, 2026:
An Act concerning pharmacists and supplementing Titles 17, 26, 45, and 52 of the Revised Statutes and Title 17B of the New Jersey Statutes. Be It Enacted by the Senate and General Assembly of the State of New Jersey: 1. As used in this act: CDC PEP guidelines means the Updated Guidelines for Antiretroviral Postexposure Prophylaxis After Sexual, Injection Drug Use, or Other Nonoccupational Exposure to HIV United States, 2016, or any subsequent guidelines, published by the federal Centers for Disease Control and Prevention. CDC PReP guidelines means the 2017 Preexposure Prophylaxis for the Prevention of HIV Infection in the United States 2017 Update: A Clinical Practice Guideline, or any subsequent guidelines, published by the federal Centers for Disease Control and Prevention. HIV means the human immunodeficiency virus. HIV preexposure prophylaxis means a fixed-dose combination of tenofovir disoproxil fumarate (TDF) (300 mg) with emtricitabine (FTC) (200 mg), or another drug or drug combination determined by the State Board of Pharmacy to meet the same clinical eligibility recommendations provided in the CEC PReP guidelines. HIV postexposure prophylaxis means: tenofovir disoproxil fumarate (TDF) (300 mg) with emtricitabine (FTC) (200 mg), taken once daily, in combination with either raltegravir (400mg), taken twice daily, or dolutegravir (50mg), taken once daily; tenofovir disoproxil fumarate (TDF) (300 mg) with emtricitabine (FTC) (200 mg), taken …
Sponsors
- Donald A. Guardian (R, 2) · primary sponsor
- Luanne M. Peterpaul, Esq. (D, 11) · primary sponsor
- Annette Quijano (D, 20) · primary sponsor
- Mitchelle Drulis (D, 16)
- Verlina Reynolds-Jackson (D, 15)
- Rosaura Bagolie (D, 27)
Latest actions
- : WITHDRAWN APP P.L.2025, c.196.
- : INT 1RA REF AHE
Subjects: HEALTH - PHARMACEUTICALS
Common questions
- What is A3675?
- A3675 is a bill in the New Jersey Legislature (2026-2027 Regular Session): HIV prophylaxis-authorizes pharmacists to dispense w/out individual prescription.
- What does A3675 do?
- In its own words: An Act concerning pharmacists and supplementing Titles 17, 26, 45, and 52 of the Revised Statutes and Title 17B of the New Jersey Statutes.
- What is the status of A3675?
- Failed as of January 30, 2026. Latest action: WITHDRAWN APP P.L.2025, c.196. (January 13, 2026).
- Who sponsored A3675?
- Donald A. Guardian (R, 2), with 5 co-sponsors.
- Where is the official record for A3675?
- On the New Jersey Legislature website: https://www.njleg.state.nj.us/bill-search/2026/A3675
Source: official New Jersey record. Tracked by Delilah, AI for legislation across all 50 states and Congress.